Vext Science, Inc. (CSE:VEXT)
Canada
· Delayed Price · Currency is CAD 0.245
0.00 (0.00%)
At close: Mar 6, 2026
Vext Science Revenue
Vext Science had revenue of $12.67M USD in the quarter ending September 30, 2025, with 40.98% growth. This brings the company's revenue in the last twelve months to $47.83M, up 39.78% year-over-year. In the year 2024, Vext Science had annual revenue of $36.00M with 3.40% growth.
Revenue (ttm)
$47.83M
Revenue Growth
+39.78%
P/S Ratio
0.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.50M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Decibel Cannabis Company | 109.31M |
| Leef Brands | 45.21M |
| Planet 13 Holdings | 151.05M |
| BioNxt Solutions | 15.82K |
| LSL Pharma Group | 26.80M |
| ZYUS Life Sciences | 465.00K |
| C21 Investments | 45.62M |
| Medexus Pharmaceuticals | 136.34M |